Follow
Mohamad Goldust
Mohamad Goldust
Yale Dermatology, New Haven, USA
No verified email - Homepage
Title
Cited by
Cited by
Year
COVID‐19 and economy
M Gupta, A Abdelmaksoud, M Jafferany, T Lotti, R Sadoughifar, M Goldust
Dermatologic therapy 33 (4), 2020
2462020
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain-A potential clue to the role of androgens in COVID-19 severity
A Goren, S Vano-Galvan, CG Wambier, J McCoy, A Gomez-Zubiaur, ...
J Cosmet Dermatol 19 (7), 1545-1547, 2020
2152020
Herpes zoster: A Review of Clinical Manifestations and Management
A Patil, M Goldust, U Wollina
Viruses 14 (2), 192, 2022
1862022
Treatment of scabies: Comparison of permethrin 5% versus ivermectin
M Goldust, E Rezaee, S Hemayat
The Journal of dermatology 39 (6), 545-547, 2012
1112012
Machine learning and its application in skin cancer
K Das, CJ Cockerell, A Patil, P Pietkiewicz, M Giulini, S Grabbe, ...
International Journal of Environmental Research and Public Health 18 (24), 13409, 2021
982021
Acanthosis nigricans: a review
A Das, D Datta, M Kassir, U Wollina, H Galadari, T Lotti, M Jafferany, ...
Journal of cosmetic dermatology 19 (8), 1857-1865, 2020
902020
Pemphigus vulgaris and bullous pemphigoid: update on diagnosis and treatment
V Di Lernia, DM Casanova, M Goldust, C Ricci
Dermatology practical & conceptual 10 (3), 2020
882020
Treatment options for leishmaniasis
S Pradhan, RA Schwartz, A Patil, S Grabbe, M Goldust
Clinical and experimental dermatology 47 (3), 516-521, 2022
782022
Complications of botulinum toxin and fillers: a narrative review
M Kassir, M Gupta, H Galadari, G Kroumpouzos, A Katsambas, T Lotti, ...
Journal of cosmetic dermatology 19 (3), 570-573, 2020
682020
Emerging drugs for the treatment of vitiligo
P Karagaiah, Y Valle, J Sigova, N Zerbinati, P Vojvodic, D Parsad, ...
Expert opinion on emerging drugs 25 (1), 7-24, 2020
682020
Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies
M Goldust, E Rezaee, R Raghifar
Cutaneous and Ocular Toxicology 33 (4), 333-336, 2014
662014
Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population.
SB Nejad, HH Qadim, L Nazeman, R Fadaii, M Goldust
Pakistan journal of biological sciences: PJBS 16 (12), 570-574, 2013
602013
Cyclosporine therapy during the COVID-19 pandemic
L Rudnicka, P Glowacka, M Goldust, M Sikora, M Sar-Pomian, ...
Journal of the American Academy of Dermatology 83 (2), e151-e152, 2020
582020
Psoriasis and respiratory comorbidities: the added value of fraction of exhaled nitric oxide as a new method to detect, evaluate, and monitor psoriatic systemic involvement and …
P Santus, M Rizzi, D Radovanovic, A Airoldi, A Cristiano, R Conic, ...
BioMed Research International 2018, 2018
582018
Scabies: a comprehensive review and current perspectives
P Arora, L Rudnicka, M Sar‐Pomian, U Wollina, M Jafferany, T Lotti, ...
Dermatologic therapy 33 (4), e13746, 2020
572020
Solidarity and transparency against the COVID‐19 pandemic
G Arora, G Kroumpouzos, M Kassir, M Jafferany, T Lotti, R Sadoughifar, ...
Dermatologic therapy 33 (4), 2020
562020
Priorities for global health community in COVID‐19 pandemic
L Rudnicka, M Gupta, M Kassir, M Jafferany, T Lotti, R Sadoughifar, ...
Dermatologic therapy 33 (4), 2020
542020
Will teledermatology be the silver lining during and after COVID‐19?
A Sharma, V Jindal, P Singla, M Goldust, M Mhatre
Dermatologic Therapy 33 (4), e13643, 2020
532020
5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety
R Dhurat, A Sharma, L Rudnicka, G Kroumpouzos, M Kassir, H Galadari, ...
Dermatologic therapy 33 (3), e13379, 2020
492020
Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum
M Goldust, EL Hagstrom, D Rathod, AG Ortega-Loayza
Expert Review of Clinical Pharmacology 13 (2), 157-161, 2020
492020
The system can't perform the operation now. Try again later.
Articles 1–20